3EM-71016-01394
2 vaccinations
8 coded responses
20 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 221 / VA
- Registered
- 2021-10-10
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-08
Dose 1 — Moderna
-
2021-10-10
Registered in v-safe
-
2021-10-10
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Swollen lymph nodes under left armpit same side as injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Swollen lymph nodes under left armpit where shot administeredMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site swelling, Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Swollen lymph nodes left armpit on injection site side. Still some swelling at injection site.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Swollen lymph nodes under armpit area on left side where injection was givenMedDRA releases: 2024-11 · check-in free text available
-
2021-10-14
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Swollen lymph nodes in left armpit where shot administeredMedDRA releases: 2024-11 · check-in free text available
-
2021-10-15
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: SwellingFree text: Monitoring swollen lymph nodes under left armpit where injection site wasMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-29
- 2021-11-05
-
2021-11-08
Dose 2 — Moderna
- 2021-11-12
- 2021-11-13
- 2021-11-14
-
2021-11-15
Survey response — day 7, dose 2MedDRA: Reaction to previous exposure to any vaccine, Skin odour abnormal — Feeling: GoodFree text: Body odor. Started with the first shot and continues with this one.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-24
- 2021-11-29
- 2021-12-08
- 2021-12-13
- 2021-12-20
- 2022-02-07
-
2022-11-08
Survey response — 12 months, dose 2MedDRA: Headache, Nasal congestion, Pain, Photophobia, Rhinorrhoea, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Gastro, runny/stuffy nose, headache, light sensitivity, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-11-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-08 | Moderna | No |
| 2 | 2021-11-08 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes under left armpit same side as injection site
Systemic reaction (other): Swollen lymph nodes under left armpit where shot administered
Systemic reaction (other): Swollen lymph nodes left armpit on injection site side. Still some swelling at injection site.
Systemic reaction (other): Swollen lymph nodes under armpit area on left side where injection was given
Systemic reaction (other): Swollen lymph nodes in left armpit where shot administered
Release 10 — day 7, dose 1
Systemic reaction (other): Monitoring swollen lymph nodes under left armpit where injection site was
Release 10 — day 7, dose 2
Systemic reaction (other): Body odor. Started with the first shot and continues with this one.
Release 12 — 12 months, dose 2
Symptoms: Gastro, runny/stuffy nose, headache, light sensitivity, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Photophobia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SRO | Skin odour abnormal | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release